카사바 사이언스, Inc.
US ˙ NasdaqCM ˙ US14817C1071
이 기호는 더 이상 활성화되지 않습니다.

SecuritySAVA / Cassava Sciences, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in SAVA / Cassava Sciences, Inc.

On May 13, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 0 shares of Cassava Sciences, Inc. (US:SAVA) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 269,470 shares of Cassava Sciences, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (SAVA) in the form of stock options. The firm currently holds call options representing 397,400 of underlying shares valued at $786,852 USD and put options representing 104,500 of underlying shares valued at $206,910 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

SAVA / Cassava Sciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F CASSAVA SCIENCES COM 14817C107 0 -269,470 -100.00 0 -100.00
2026-02-11 2025-12-31 13F CASSAVA SCIENCES COM 14817C107 269,470 67,854 33.66 534 -9.04 0.0009
2025-11-12 2025-09-30 13F CASSAVA SCIENCES COM 14817C107 201,616 -14,738 -6.81 587 49.87 0.0010
2025-08-14 2025-06-30 13F CASSAVA SCIENCES COM 14817C107 216,354 121,429 127.92 392 175.35 0.0009
2025-05-14 2025-03-31 13F CASSAVA SCIENCES COM 14817C107 94,925 94,925 142 0.0004
2025-05-14 2024-12-31 13F/A-1 CASSAVA SCIENCES COM 14817C107 0 -130,789 -100.00 0 -100.00
2025-02-14 2024-12-31 13F CASSAVA SCIENCES COM 14817C107 0 -130,789 0
2024-11-14 2024-09-30 13F CASSAVA SCIENCES COM 14817C107 130,789 130,789 3,849 0.0110
2024-08-14 2024-06-30 13F CASSAVA SCIENCES COM 14817C107 0 -4,694 -100.00 0 -100.00
2024-05-10 2024-03-31 13F CASSAVA SCIENCES COM 14817C107 4,694 4,694 95 0.0004
2023-11-09 2023-09-30 13F CASSAVA SCIENCES COM 14817C107 0 -45,936 -100.00 0 -100.00
2023-08-09 2023-06-30 13F CASSAVA SCIENCES COM 14817C107 45,936 45,936 1,126 0.0036
2023-05-12 2023-03-31 13F CASSAVA SCIENCES COM 14817C107 0 -104,520 -100.00 0 -100.00
2023-02-09 2022-12-31 13F CASSAVA SCIENCES COM 14817C107 104,520 104,520 3,088 0.0072
2022-11-09 2022-09-30 13F CASSAVA SCIENCES COM 14817C107 0 -23,682 -100.00 0 -100.00
2022-08-11 2022-06-30 13F CASSAVA SCIENCES COM 14817C107 23,682 -205,082 -89.65 666 -92.16 0.0010
2022-05-12 2022-03-31 13F CASSAVA SCIENCES COM 14817C107 228,764 142,102 163.97 8,496 124.35 0.0084
2022-02-11 2021-12-31 13F CASSAVA SCIENCES COM 14817C107 86,662 -321,190 -78.75 3,787 -85.04 0.0030
2021-11-12 2021-09-30 13F CASSAVA SCIENCES COM 14817C107 407,852 -136,733 -25.11 25,319 -45.58 0.0273
2021-08-10 2021-06-30 13F CASSAVA SCIENCES COM 14817C107 544,585 124,202 29.54 46,529 146.24 0.0561
2021-05-12 2021-03-31 13F CASSAVA SCIENCES COM 14817C107 420,383 358,594 580.35 18,896 4,388.36 0.0280
2021-02-10 2020-12-31 13F CASSAVA SCIENCES COM 14817C107 61,789 -61,380 -49.83 421 -70.31 0.0007
2020-11-12 2020-09-30 13F CASSAVA SCIENCES COM 14817C107 123,169 -98,462 -44.43 1,418 107.61 0.0045
2020-08-13 2020-06-30 13F CASSAVA SCIENCES COM 14817C107 221,631 212,040 2,210.82 683 1,651.28 0.0032
2020-05-13 2020-03-31 13F CASSAVA SCIENCES COM 14817C107 9,591 9,448 6,606.99 39 3,800.00 0.0003
2020-02-10 2019-12-31 13F CASSAVA SCIENCES COM 14817C107 143 0 0.00 1 0.0000
2019-11-12 2019-09-30 13F CASSAVA SCIENCES COM 14817C107 143 0 0.00 0 0.0000
2019-08-09 2019-06-30 13F CASSAVA SCIENCES COM 14817C107 143 0 0.00 0 0.0000
2019-05-14 2019-03-31 13F/A-1 CASSAVA SCIENCES COM 14817C107 143 143 0 0.0000
2019-05-13 2019-03-31 13F CASSAVA SCIENCES COM 14817C107 143 0
2019-02-05 2018-12-31 13F PAIN THERAPEUTICS COM NEW 69562K506 143 0 0.00 0 0.0000
2018-11-08 2018-09-30 13F PAIN THERAPEUTICS COM NEW 69562K506 143 0 0.00 0 0.0000
2018-08-13 2018-06-30 13F PAIN THERAPEUTICS COM NEW 69562K506 143 0 0.00 0 -100.00
2018-05-16 2018-03-31 13F/A-1 PAIN THERAPEUTICS COM NEW 69562K506 143 0 0.00 1 0.00 0.0000
2018-05-10 2018-03-31 13F PAIN THERAPEUTICS COM NEW 69562K506 143 0 1
2018-02-09 2017-12-31 13F PAIN THERAPEUTICS COM NEW 69562K506 143 -2,420 -94.42 1 -90.00 0.0000
2017-11-15 2017-09-30 13F PAIN THERAPEUTICS COM NEW 69562K506 2,563 0 0.00 10 -9.09 0.0001
2017-08-14 2017-06-30 13F PAIN THERAPEUTICS COM NEW 69562K506 2,563 -15,371 -85.71 11 -31.25 0.0001
2017-05-10 2017-03-31 13F PAIN THERAPEUTICS COM 69562K100 17,934 0 0.00 16 60.00 0.0002
2017-02-15 2016-12-31 13F PAIN THERAPEUTICS COM 69562K100 17,934 4,300 31.54 10 -28.57 0.0001
2016-11-14 2016-09-30 13F PAIN THERAPEUTICS COM 69562K100 13,634 2,747 25.23 14 -53.33 0.0002
2013-11-15 2013-09-30 13F PAIN THERAPEUTICS COM 69562K100 10,887 10,887 30 0.0006
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F CASSAVA SCIENCES COM Call 397,400 -17.35 787 -43.82 n/a n/a n/a
2025-11-12 2025-09-30 13F CASSAVA SCIENCES COM Call 480,800 31.22 1,399 111.01 n/a n/a n/a
2025-08-14 2025-06-30 13F CASSAVA SCIENCES COM Call 366,400 -27.21 663 -12.19 n/a n/a n/a
2025-05-14 2025-03-31 13F CASSAVA SCIENCES COM Call 503,400 -24.16 755 -51.79 n/a n/a n/a
2025-05-14 2024-12-31 13F/A CASSAVA SCIENCES COM Call 663,800 10.27 1,567 -91.16 n/a n/a n/a
2025-02-14 2024-12-31 13F CASSAVA SCIENCES COM Call 663,800 1,567 n/a n/a n/a
2024-11-14 2024-09-30 13F CASSAVA SCIENCES COM Call 602,000 -5.08 17,717 126.20 n/a n/a n/a
2024-08-14 2024-06-30 13F CASSAVA SCIENCES COM Call 634,200 31.63 7,832 -19.88 n/a n/a n/a
2024-05-10 2024-03-31 13F CASSAVA SCIENCES COM Call 481,800 -52.45 9,776 -57.14 n/a n/a n/a
2024-02-14 2023-12-31 13F CASSAVA SCIENCES COM Call 1,013,200 91.28 22,807 158.76 n/a n/a n/a
2023-11-09 2023-09-30 13F CASSAVA SCIENCES COM Call 529,700 76.04 8,814 19.46 n/a n/a n/a
2023-08-09 2023-06-30 13F CASSAVA SCIENCES COM Call 300,900 -34.97 7,378 -33.89 n/a n/a n/a
2023-05-12 2023-03-31 13F CASSAVA SCIENCES COM Call 462,700 -56.00 11,160 -64.07 n/a n/a n/a
2023-02-09 2022-12-31 13F CASSAVA SCIENCES COM Call 1,051,600 -15.62 31,064 -40.40 n/a n/a n/a
2022-11-09 2022-09-30 13F CASSAVA SCIENCES COM Call 1,246,300 53.01 52,120 127.56 n/a n/a n/a
2022-08-11 2022-06-30 13F CASSAVA SCIENCES COM Call 814,500 76.41 22,904 33.57 n/a n/a n/a
2022-05-12 2022-03-31 13F CASSAVA SCIENCES COM Call 461,700 -34.76 17,148 -44.55 n/a n/a n/a
2022-02-11 2021-12-31 13F CASSAVA SCIENCES COM Call 707,700 38.25 30,926 -2.68 n/a n/a n/a
2021-11-12 2021-09-30 13F CASSAVA SCIENCES COM Call 511,900 147.29 31,779 79.68 n/a n/a n/a
2021-08-10 2021-06-30 13F CASSAVA SCIENCES COM Call 207,000 -57.01 17,686 -18.28 n/a n/a n/a
2021-05-12 2021-03-31 13F CASSAVA SCIENCES COM Call 481,500 314.37 21,643 2,632.70 n/a n/a n/a
2021-02-10 2020-12-31 13F CASSAVA SCIENCES COM Call 116,200 30.27 792 -22.88 n/a n/a n/a
2020-11-12 2020-09-30 13F CASSAVA SCIENCES COM Call 89,200 -53.22 1,027 74.96 n/a n/a n/a
2020-08-13 2020-06-30 13F CASSAVA SCIENCES COM Call 190,700 6,475.86 587 4,791.67 n/a n/a n/a
2020-05-13 2020-03-31 13F CASSAVA SCIENCES COM Call 2,900 12 n/a n/a n/a
2015-02-11 2014-12-31 13F PAIN THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-10-31 2014-09-30 13F PAIN THERAPEUTICS COM Call 18,700 -42.99 73 -61.38 n/a n/a n/a
2014-08-12 2014-06-30 13F PAIN THERAPEUTICS COM Call 32,800 -34.66 189 -31.52 n/a n/a n/a
2014-05-07 2014-03-31 13F PAIN THERAPEUTICS COM Call 50,200 147.29 276 178.79 n/a n/a n/a
2014-01-31 2013-12-31 13F PAIN THERAPEUTICS COM Call 20,300 72.03 99 209.38 n/a n/a n/a
2013-11-15 2013-09-30 13F PAIN THERAPEUTICS COM Call 11,800 -56.93 32 -47.54 n/a n/a n/a
2013-08-02 2013-06-30 13F PAIN THERAPEUTICS COM Call 27,400 61 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F CASSAVA SCIENCES COM Put 104,500 22.94 207 -16.60 n/a n/a n/a
2025-11-12 2025-09-30 13F CASSAVA SCIENCES COM Put 85,000 1.80 247 63.58 n/a n/a n/a
2025-08-14 2025-06-30 13F CASSAVA SCIENCES COM Put 83,500 -25.78 151 -10.12 n/a n/a n/a
2025-05-14 2025-03-31 13F CASSAVA SCIENCES COM Put 112,500 -85.58 169 -90.87 n/a n/a n/a
2025-05-14 2024-12-31 13F/A CASSAVA SCIENCES COM Put 780,400 -23.14 1,842 -93.84 n/a n/a n/a
2025-02-14 2024-12-31 13F CASSAVA SCIENCES COM Put 780,400 1,842 n/a n/a n/a
2024-11-14 2024-09-30 13F CASSAVA SCIENCES COM Put 1,015,300 761.15 29,880 1,952.20 n/a n/a n/a
2024-08-14 2024-06-30 13F CASSAVA SCIENCES COM Put 117,900 -35.50 1,456 -60.74 n/a n/a n/a
2024-05-10 2024-03-31 13F CASSAVA SCIENCES COM Put 182,800 -38.88 3,709 -44.90 n/a n/a n/a
2024-02-14 2023-12-31 13F CASSAVA SCIENCES COM Put 299,100 377.80 6,733 546.69 n/a n/a n/a
2023-11-09 2023-09-30 13F CASSAVA SCIENCES COM Put 62,600 -16.42 1,042 -43.30 n/a n/a n/a
2023-08-09 2023-06-30 13F CASSAVA SCIENCES COM Put 74,900 57.02 1,837 59.65 n/a n/a n/a
2023-05-12 2023-03-31 13F CASSAVA SCIENCES COM Put 47,700 -90.82 1,151 -92.51 n/a n/a n/a
2023-02-09 2022-12-31 13F CASSAVA SCIENCES COM Put 519,600 -11.04 15,349 -37.17 n/a n/a n/a
2022-11-09 2022-09-30 13F CASSAVA SCIENCES COM Put 584,100 0.45 24,427 49.38 n/a n/a n/a
2022-08-11 2022-06-30 13F CASSAVA SCIENCES COM Put 581,500 66.91 16,352 26.37 n/a n/a n/a
2022-05-12 2022-03-31 13F CASSAVA SCIENCES COM Put 348,400 -4.76 12,940 -19.05 n/a n/a n/a
2022-02-11 2021-12-31 13F CASSAVA SCIENCES COM Put 365,800 -21.15 15,985 -44.49 n/a n/a n/a
2021-11-12 2021-09-30 13F CASSAVA SCIENCES COM Put 463,900 119.44 28,799 59.45 n/a n/a n/a
2021-08-10 2021-06-30 13F CASSAVA SCIENCES COM Put 211,400 49.93 18,062 184.98 n/a n/a n/a
2021-05-12 2021-03-31 13F CASSAVA SCIENCES COM Put 141,000 1,046.34 6,338 7,445.24 n/a n/a n/a
2021-02-10 2020-12-31 13F CASSAVA SCIENCES COM Put 12,300 11.82 84 -33.86 n/a n/a n/a
2020-11-12 2020-09-30 13F CASSAVA SCIENCES COM Put 11,000 -39.23 127 126.79 n/a n/a n/a
2020-08-13 2020-06-30 13F CASSAVA SCIENCES COM Put 18,100 217.54 56 143.48 n/a n/a n/a
2020-05-13 2020-03-31 13F CASSAVA SCIENCES COM Put 5,700 23 n/a n/a n/a
2015-02-11 2014-12-31 13F PAIN THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2014-10-31 2014-09-30 13F PAIN THERAPEUTICS COM Put 600 -33.33 2 -60.00 n/a n/a n/a
2014-08-12 2014-06-30 13F PAIN THERAPEUTICS COM Put 900 -88.16 5 -88.10 n/a n/a n/a
2014-05-07 2014-03-31 13F PAIN THERAPEUTICS COM Put 7,600 533.33 42 600.00 n/a n/a n/a
2014-01-31 2013-12-31 13F PAIN THERAPEUTICS COM Put 1,200 -72.73 6 -50.00 n/a n/a n/a
2013-11-15 2013-09-30 13F PAIN THERAPEUTICS COM Put 4,400 25.71 12 50.00 n/a n/a n/a
2013-08-02 2013-06-30 13F PAIN THERAPEUTICS COM Put 3,500 8 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.